Publications

30 Mar 2023
Video

Generating Breakthrough Therapies: Risk and Reward

November 2016
Case

Transformation at Eli Lilly & Co. (A)

By: William R. Kerr and Alexis Brownell

Faced with the imminent loss of 40% of its revenues due to patent expirations, pharma giant Eli Lilly sets out on a dramatic transformation process in 2009. The case considers how Lilly restructured the organization into business areas to aid better decision-making,... View Details

Keywords: Eli Lilly; Restructuring; R＆D; Transformation; Organizational Change and Adaptation; Organizational Structure; Pharmaceutical Industry; Indianapolis

29 Jun 2021
News

What Does the Future of Work Look Like for America’s Biopharma Sales Force?

16 Mar 2021
News

Robert Kaplan: The essence of long-term strategy

June 1998
Supplement

MBA Integrative Exercise: Competition & Strategy, April 1998 , Video

By: Carin-Isabel Knoop

Daniel Vasella, President of Novartis AG, discusses the situation in Indonesia and his ideas of what Suharto should do in the spring of 1998. Drummond Paris, Regional Pharma Head Asia/Pacific, Novartis AG, discusses the opportunities for Novartis in Indonesia and also... View Details

Keywords: Competitive Strategy; Pharmaceutical Industry; Indonesia

09 Jun 2015
News

How Merck Is Trying to Keep Disrupters at Bay

30 Dec 2010
News

Shrink It, Cure It

14 Feb 2017
News

Want to build better patient relationships? Take a page from consumer marketers, advises Harvard fellow

27 Feb 2024
Blog Post

Fighting Cancer with a Novel Cell Therapy: Ananya Zutshi (MS/MBA '21)

originally planned to pursue a Ph.D., but instead spent four years at Catalent Pharma Solutions, a leading pharma/biotech contract manufacturing development organization. Surrounded by potential career paths in the industry, Zutshi... View Details

26 Apr 2019
HBS Seminar

Maryaline Catillon, Harvard University

November 2007
Supplement

Teva Pharmaceutical Industries, Ltd.

By: Tarun Khanna and Krishna G. Palepu

How do companies develop a strategy that is both low-cost and differentiated without becoming squeezed in the middle? Describes how Teva, Israel's largest and first multinational, achieved its globally dominant position in generic pharmaceuticals, an industry that has... View Details

Keywords: Multinational Firms and Management; Emerging Markets; Rank and Position; Competitive Strategy; Pharmaceutical Industry; Israel; India

10 Dec 2018
News

Did Free Pens Cause the Opioid Crisis?

October 2023 (Revised May 2024)
Case

Thermo Fisher Scientific: Foray into Contract Research

By: Satish Tadikonda, William Marks and Kevin Emancipator

After publicly declaring that they would not enter the contract research organization (CRO) business in 2017, Thermo Fisher purchased Pharmaceutical Product Development (PPD), one of the biggest players in the CRO space, in 2021. Much had changed in the intervening... View Details

Keywords: Mergers and Acquisitions; Customer Focus and Relationships; Corporate Strategy; Organizational Change and Adaptation; Biotechnology Industry

January 2018
Case

Spark Therapeutics: Pioneering Gene Therapy

By: Robert F. Higgins and Tina Liu

Spark Therapeutics is a pioneering gene therapy startup. It was spun out of The Children’s Hospital of Philadelphia (CHOP). The company had taken with it much of the intellectual property and talent that CHOP had developed. The company is considering an initial public... View Details

Keywords: Health Care and Treatment; Innovation and Invention; Business Startups; Opportunities; Problems and Challenges; Strategy